Ravit Arav-Boger

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Venues

Journal of virology

Viruses

Clinical and vaccine immunology : CVI

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Guy Shapira, Hadas Volkov, Itai Fabian, David W Mohr, Maria Bettinotti, Noam Shomron, Robin K Avery, Ravit Arav-Boger
Genomic Markers Associated with Cytomegalovirus DNAemia in Kidney Transplant Recipients. Viruses 15 (11) (2023)
Ayan K Ghosh, Yu-Pin Su, Michael Forman, Robert F Keyes, Brian C Smith, Xin Hu, Marc Ferrer, Ravit Arav-Boger
Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control. Journal of virology (2023)
Ayan K Ghosh, Yu-Pin Su, Michael Forman, Robert F Keyes, Brian C Smith, Xin Hu, Marc Ferrer, Ravit Arav-Boger
Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control. Journal of virology (2023)
Xin Guo, Ayan Kumar Ghosh, Robert F Keyes, Francis Peterson, Michael Forman, David J Meyers, Ravit Arav-Boger
The Synthesis and Anti-Cytomegalovirus Activity of Piperidine-4-Carboxamides. Viruses 14 (2) (2022)
Ayan Kumar Ghosh, Halli Miller, Konstance Knox, Madhuchhanda Kundu, Kelly J Henrickson, Ravit Arav-Boger
Inhibition of Human Coronaviruses by Antimalarial Peroxides. ACS infectious diseases 7 (7) (2021)
Arun Kapoor, Ayan K Ghosh, Michael Forman, Xin Hu, Wenjuan Ye, Noel Southall, Juan Marugan, Robert F Keyes, Brian C Smith, David J Meyers, Marc Ferrer, Ravit Arav-Boger
Validation and Characterization of Five Distinct Novel Inhibitors of Human Cytomegalovirus. Journal of medicinal chemistry 63 (8) (2020)
Cody S Nelson, Diana Vera Cruz, Melody Su, Guanhua Xie, Nathan Vandergrift, Robert F Pass, Michael Forman, Marie Diener-West, Katia Koelle, Ravit Arav-Boger, Sallie R Permar
Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees. Journal of virology 93 (5) (2019)
Joseph W Jackson, Trevor J Hancock, Pranay Dogra, Ravi Patel, Ravit Arav-Boger, Angela D Williams, Stephen J Kennel, Jonathan S Wall, Tim E Sparer
Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of In Vitro Screenings. mSphere 4 (1) (2019)
Rupkatha Mukhopadhyay, Rajkumar Venkatadri, Jenny Katsnelson, Ravit Arav-Boger
Digitoxin Suppresses Human Cytomegalovirus Replication via Na+, K+/ATPase α1 Subunit-Dependent AMP-Activated Protein Kinase and Autophagy Activation. Journal of virology 92 (6) (2018)
Yiping Wang, Rupkatha Mukhopadhyay, Sujayita Roy, Arun Kapoor, Yu-Pin Su, Susan A Charman, Gong Chen, Jianbo Wu, Xiaofang Wang, Jonathan L Vennerstrom, Ravit Arav-Boger
Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic Ozonides. Antimicrobial agents and chemotherapy 63 (1) (2018)
Xiaohong Cui, Stuart P Adler, Mark R Schleiss, Ravit Arav-Boger, Gail J Demmler Harrison, Michael A McVoy
Cytomegalovirus Virions Shed in Urine Have a Reversible Block to Epithelial Cell Entry and Are Highly Resistant to Antibody Neutralization. Clinical and vaccine immunology : CVI 24 (6) (2017)

Ravit Arav-Boger.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ravit Arav-Boger